Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?

Gerard J Abood, Brian J Nickoloff, Richard L Gamelli

Journal: Journal of burn care & research : official publication of the American Burn Association 2008;29(1):269-76

PMID: 18182932

Abstract

Toxic epidermal necrolysis syndrome (TENS) is a rare, life-threatening medical emergency typically associated with recent drug exposure. Although several theories exist, recent insight has implicated the innate immune system as a significant contributor to the initiation and propagation of this devastating reaction. Standard therapies including transfer to specialized burn units, nutritional support, and protection from infection, remain the mainstay in the treatment of TENS. While alternative treatment strategies have been pursued and reported, there remains no published data that convincingly supports these further interventions. Given the rare nature of this syndrome, multi-institutional studies will be necessary and essential in improving the understanding and treatment of TENS.

Address: Department of Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.